Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (261-270 of 451) with videos related to

Pageof 46
Sort By:
JAMA|October 21, 1988
The TPA controversy and the drug approval process. The view of the Cardiovascular and Renal Drugs Advisory CommitteeP R Kowey, L Fisher, E G Giardina, et al.
Pacing and Clinical Electrophysiology : PACE|February 1, 1991
Device interaction--antitachycardia pacemakers and defibrillators for sustained ventricular tachycardiaT S Ahern, C Nydegger, D J McCormick, et al.
JAMA Internal Medicine|March 3, 2015
Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulationEmily C O'Brien, Sunghee Kim, Paul L Hess, et al.
American Heart Journal|March 31, 2000
Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmiasR I Fogel, J M Herre, H A Kopelman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 19, 2002
Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophyXiaoping Xu, Joseph J Salata, Jixin Wang, et al.
Circulation|March 21, 2001
Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbitsX Xu, S J Rials, Y Wu, et al.
Heart Rhythm|August 7, 2007
Does Tpeak-Tend provide an index of transmural dispersion of repolarization?Charles Antzelevitch, Serge Sicouri, José M Di Diego, et al.
American Heart Journal|October 1, 1984
Vulnerability to ventricular fibrillation in patients with clinically manifest ventricular tachycardiaP R Kowey, S Khuri, M Josa, et al.
Circulation. Arrhythmia and Electrophysiology|August 1, 2015
The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic SynergismJames A Reiffel, A John Camm, Luiz Belardinelli, et al.
JAMA Cardiology|August 27, 2017
Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF StudyJames A Reiffel, Atul Verma, Peter R Kowey, et al.
Pageof 46

Showing results (261-270 of 451) with videos related to

Sort By:
Pageof 46
JAMA|October 21, 1988
The TPA controversy and the drug approval process. The view of the Cardiovascular and Renal Drugs Advisory CommitteeP R Kowey, L Fisher, E G Giardina, et al.
Pacing and Clinical Electrophysiology : PACE|February 1, 1991
Device interaction--antitachycardia pacemakers and defibrillators for sustained ventricular tachycardiaT S Ahern, C Nydegger, D J McCormick, et al.
JAMA Internal Medicine|March 3, 2015
Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulationEmily C O'Brien, Sunghee Kim, Paul L Hess, et al.
American Heart Journal|March 31, 2000
Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmiasR I Fogel, J M Herre, H A Kopelman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 19, 2002
Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophyXiaoping Xu, Joseph J Salata, Jixin Wang, et al.
Circulation|March 21, 2001
Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbitsX Xu, S J Rials, Y Wu, et al.
Heart Rhythm|August 7, 2007
Does Tpeak-Tend provide an index of transmural dispersion of repolarization?Charles Antzelevitch, Serge Sicouri, José M Di Diego, et al.
American Heart Journal|October 1, 1984
Vulnerability to ventricular fibrillation in patients with clinically manifest ventricular tachycardiaP R Kowey, S Khuri, M Josa, et al.
Circulation. Arrhythmia and Electrophysiology|August 1, 2015
The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic SynergismJames A Reiffel, A John Camm, Luiz Belardinelli, et al.
JAMA Cardiology|August 27, 2017
Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF StudyJames A Reiffel, Atul Verma, Peter R Kowey, et al.
Pageof 46